Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (window အသစ် ဖွင့်နေပါတယ်)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

ရင်းမြစ်‎: Cancer 2013;119(21):3784-7.

Index လုပ်ထား‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (window အသစ် ဖွင့်နေပါတယ်)

Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. (window အသစ် ဖွင့်နေပါတယ်)

Avvisati G, ten Cate JW, Büller HR, Mandelli F.

ရင်းမြစ်‎: Lancet 1989;334(8655):122-4.

Index လုပ်ထား‎: PubMed 2567893

https://www.ncbi.nlm.nih.gov/pubmed/2567893 (window အသစ် ဖွင့်နေပါတယ်)

Tranexamic acid therapy in acute myeloid leukemia: possible reduction of platelet transfusions. (window အသစ် ဖွင့်နေပါတယ်)

Ben-Bassat I, Douer D, Ramot B.

ရင်းမြစ်‎: Eur J Haematol 1990;45(2):86-9.

Index လုပ်ထား‎: PubMed 2209824

https://www.ncbi.nlm.nih.gov/pubmed/2209824 (window အသစ် ဖွင့်နေပါတယ်)

Fibrinolytic inhibitors for cancer-associated bleeding problems. (window အသစ် ဖွင့်နေပါတယ်)

Dean A, Tuffin P.

ရင်းမြစ်‎: J Pain Symptom Manage 1997;13(1):20-4.

Index လုပ်ထား‎: PubMed 9029858

https://www.ncbi.nlm.nih.gov/pubmed/9029858 (window အသစ် ဖွင့်နေပါတယ်)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (window အသစ် ဖွင့်နေပါတယ်)

Ford PA, Grant SJ, Mick R, Keck G.

ရင်းမြစ်‎: J Clin Oncol 2015;33(15):1674-9.

Index လုပ်ထား‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (window အသစ် ဖွင့်နေပါတယ်)

Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients. (window အသစ် ဖွင့်နေပါတယ်)

Garewal HS, Durie BG.

ရင်းမြစ်‎: Scand J Haematol 1985;35(5):497-500.

Index လုပ်ထား‎: PubMed 4089529

https://www.ncbi.nlm.nih.gov/pubmed/4089529 (window အသစ် ဖွင့်နေပါတယ်)

Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. (window အသစ် ဖွင့်နေပါတယ်)

Kalmadi S, Tiu R, Lowe C, Jin T, Kalaycio M.

ရင်းမြစ်‎: Cancer 2006;107(1):136-40.

Index လုပ်ထား‎: PubMed 16708357

DOI‎: 10.1002/cncr.21958

https://www.ncbi.nlm.nih.gov/pubmed/16708357 (window အသစ် ဖွင့်နေပါတယ်)

Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series. (window အသစ် ဖွင့်နေပါတယ်)

Marshall A, Li A, Drucker A, Dzik W.

ရင်းမြစ်‎: Hematol Oncol 2016;34(3):147-53.

Index လုပ်ထား‎: PubMed 25641349

DOI‎: 10.1002/hon.2189

https://www.ncbi.nlm.nih.gov/pubmed/25641349 (window အသစ် ဖွင့်နေပါတယ်)

Tranexamic acid to treat life-threatening hemorrhage in prostate cancer associated disseminated intravascular coagulation with excessive fibrinolysis. (window အသစ် ဖွင့်နေပါတယ်)

Prokopchuk-Gauk O, Brose K.

ရင်းမြစ်‎: Cureus 2015;7(12):e428.

Index လုပ်ထား‎: PubMed 26848417

DOI‎: 10.7759/cureus.428

https://www.ncbi.nlm.nih.gov/pubmed/26848417 (window အသစ် ဖွင့်နေပါတယ်)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (window အသစ် ဖွင့်နေပါတယ်)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

ရင်းမြစ်‎: Leuk Lymphoma 1995;19(1-2):141-4.

Index လုပ်ထား‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (window အသစ် ဖွင့်နေပါတယ်)

Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients. (window အသစ် ဖွင့်နေပါတယ်)

Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E.

ရင်းမြစ်‎: Hematol Oncol 2008;26(4):241-6.

Index လုပ်ထား‎: PubMed 18613223

DOI‎: 10.1002/hon.867

https://www.ncbi.nlm.nih.gov/pubmed/18613223 (window အသစ် ဖွင့်နေပါတယ်)

Use of Novoseven for arsenic trioxide-induced bleeding in PML. (window အသစ် ဖွင့်နေပါတယ်)

Alimoghaddam K, Ghavamzadeh A, Jahani M.

ရင်းမြစ်‎: Am J Hematol 2006;81(9):720.

Index လုပ်ထား‎: PubMed 16804937

DOI‎: 10.1002/ajh.20713

https://www.ncbi.nlm.nih.gov/pubmed/16804937 (window အသစ် ဖွင့်နေပါတယ်)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (window အသစ် ဖွင့်နေပါတယ်)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

ရင်းမြစ်‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Index လုပ်ထား‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (window အသစ် ဖွင့်နေပါတယ်)

The off-label use of recombinant FVIIa in the treatment of a patient with T-cell non-Hodgkin lymphoma who developed intra-abdominal and intra-pleural hemorrhages followed by high-dose methotreaxate therapy. (window အသစ် ဖွင့်နေပါတယ်)

Erduran E, Bahadir A, Mutlu M.

ရင်းမြစ်‎: Eur J Clin Med Oncol 2011;3(5):1-4.

Index လုပ်ထား‎: EMBASE 2012295551

https://www.worldcat.org/title/european-journal-of-clinical-medical-oncology/oclc/645421559&referer=brief_results (window အသစ် ဖွင့်နေပါတယ်)

The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review. (window အသစ် ဖွင့်နေပါတယ်)

Franchini M, Veneri D, Lippi G.

ရင်းမြစ်‎: Bone Marrow Transplant 2007;39(12):729-35.

Index လုပ်ထား‎: PubMed 17417659

DOI‎: 10.1038/sj.bmt.1705670

https://www.ncbi.nlm.nih.gov/pubmed/17417659 (window အသစ် ဖွင့်နေပါတယ်)

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (window အသစ် ဖွင့်နေပါတယ်)

Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.

ရင်းမြစ်‎: Am J Hematol 2002;69(3):219-22.

Index လုပ်ထား‎: PubMed 11891811

https://www.ncbi.nlm.nih.gov/pubmed/11891811 (window အသစ် ဖွင့်နေပါတယ်)

Use of recombinant activated factor VII in a Jehovah's Witness patient. (window အသစ် ဖွင့်နေပါတယ်)

Hsieh A, Cheong I.

ရင်းမြစ်‎: Am J Emerg Med 2007;25(9):1085.e1-2.

Index လုပ်ထား‎: PubMed 18022514

DOI‎: 10.1016/j.ajem.2007.03.007

https://www.ncbi.nlm.nih.gov/pubmed/18022514 (window အသစ် ဖွင့်နေပါတယ်)

Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. (window အသစ် ဖွင့်နေပါတယ်)

Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U.

ရင်းမြစ်‎: Haemostasis 1996;26 Suppl 1:159-64.

Index လုပ်ထား‎: PubMed 8904193

https://www.ncbi.nlm.nih.gov/pubmed/8904193 (window အသစ် ဖွင့်နေပါတယ်)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (window အသစ် ဖွင့်နေပါတယ်)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

ရင်းမြစ်‎: Med Oncol 2010;27(1):16-9.

Index လုပ်ထား‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (window အသစ် ဖွင့်နေပါတယ်)

Recombinant factor VIIa for bleeding in refractory thrombocytopenia. (window အသစ် ဖွင့်နေပါတယ်)

Vidarsson B, Önundarson PT.

ရင်းမြစ်‎: Thromb Haemost 2000;83(4):634-5.

Index လုပ်ထား‎: PubMed 10780334

https://www.ncbi.nlm.nih.gov/pubmed/10780334 (window အသစ် ဖွင့်နေပါတယ်)

Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. (window အသစ် ဖွင့်နေပါတယ်)

Zver S, Andoljšek D, Černelč P.

ရင်းမြစ်‎: Eur J Haematol 2004;72(6):455-6.

Index လုပ်ထား‎: PubMed 15128428

DOI‎: 10.1111/j.1600-0609.2004.00237.x

https://www.ncbi.nlm.nih.gov/pubmed/15128428 (window အသစ် ဖွင့်နေပါတယ်)

Management of bleeding complications of hematologic malignancies. (window အသစ် ဖွင့်နေပါတယ်)

Green D.

ရင်းမြစ်‎: Semin Thromb Hemost 2007;33(4):427-34.

Index လုပ်ထား‎: PubMed 17525900

DOI‎: 10.1055/s-2007-976178

https://www.ncbi.nlm.nih.gov/pubmed/17525900 (window အသစ် ဖွင့်နေပါတယ်)

Vitamin K deficiency in cancer patients referred to a hospital palliative care team with bleeding and the impact of vitamin K replacement on laboratory indicators of vitamin K status. (window အသစ် ဖွင့်နေပါတယ်)

Harrington DJ, Booth L, Dando N, Cottingham L, Beynon T.

ရင်းမြစ်‎: Int J Lab Hematol 2013;35(4):457-9.

Index လုပ်ထား‎: PubMed 23216984

DOI‎: 10.1111/ijlh.12035

https://www.ncbi.nlm.nih.gov/pubmed/23216984 (window အသစ် ဖွင့်နေပါတယ်)

Management of bleeding in patients with advanced cancer. (window အသစ် ဖွင့်နေပါတယ်)

Pereira J, Phan T.

ရင်းမြစ်‎: Oncologist 2004;9(5):561-70.

Index လုပ်ထား‎: PubMed 15477642

DOI‎: 10.1634/theoncologist.9-5-561

https://www.ncbi.nlm.nih.gov/pubmed/15477642 (window အသစ် ဖွင့်နေပါတယ်)

Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies. (window အသစ် ဖွင့်နေပါတယ်)

Castaman G, Bona ED, Schiavotto C, Trentin L, D'Emilio A, Rodeghiero F.

ရင်းမြစ်‎: Haematologica 1997;82(5):584-7.

Index လုပ်ထား‎: PubMed 9407726

https://www.ncbi.nlm.nih.gov/pubmed/9407726 (window အသစ် ဖွင့်နေပါတယ်)

Desmopressin and other synthetic vasopressin analogues in cancer treatment. (window အသစ် ဖွင့်နေပါတယ်)

Gomez DE, Ripoll GV, Girón S, Alonso DF.

ရင်းမြစ်‎: Bull Cancer 2006;93(2):E7-12.

Index လုပ်ထား‎: PubMed 16517412

https://www.ncbi.nlm.nih.gov/pubmed/16517412 (window အသစ် ဖွင့်နေပါတယ်)